STOCK TITAN

BCAX (NASDAQ: BCAX) insider plans sale of 1,882 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BCAX insider Ivan Hyep has filed a Form 144 notice to sell 1,882 shares of common stock through UBS Financial Services, Inc., with an aggregate market value of $34,158.30 on NASDAQ around 01/22/2026. These shares were acquired the same day via a cash exercise of stock options from the issuer. The filing notes that 54,781,950 shares of this class were outstanding. Over the past three months, the same seller reported additional BCAX common stock sales totaling several thousand shares, with gross proceeds including $168,491.56, $10,980.75, and $330,093.69.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the BCAX Form 144 filed by Ivan Hyep disclose?

The Form 144 states that Ivan Hyep plans to sell 1,882 shares of BCAX common stock through UBS Financial Services, Inc., with an aggregate market value of $34,158.30 on NASDAQ around 01/22/2026.

How did the BCAX shares being sold under this Form 144 get acquired?

The 1,882 BCAX common shares covered by this notice were acquired on 01/22/2026 through an exercise of stock options from the issuer, paid for in cash on the same date.

How many BCAX shares are outstanding in the class being sold?

The filing reports that there were 54,781,950 shares of BCAX common stock outstanding in the relevant class.

Which broker and exchange are involved in this BCAX Form 144 sale?

The planned sale will be executed through UBS Financial Services, Inc., with the shares listed for trading on the NASDAQ stock market.

What prior BCAX stock sales by Ivan Hyep are reported in the last 3 months?

The notice lists three prior BCAX common stock sales by Ivan Hyep in the past three months: 9,200 shares on 12/22/2025 for $168,491.56, 605 shares on 11/21/2025 for $10,980.75, and 17,795 shares on 11/24/2025 for $330,093.69.

What representation does the BCAX insider make when signing the Form 144?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Bicara Therapeutics

NASDAQ:BCAX

BCAX Rankings

BCAX Latest News

BCAX Latest SEC Filings

BCAX Stock Data

899.52M
45.05M
12.23%
93.98%
9.88%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON